Display options
Cite
Siddiqui R, Gawande S, Shende T, et al. SSRI-induced coagulopathy: is it reality?. Ther Adv Psychopharmacol. 2011;1(6):169-74doi: 10.1177/2045125311423781.
Siddiqui, R., Gawande, S., Shende, T., Tadke, R., Bhave, S., & Kirpekar, V. (2011). SSRI-induced coagulopathy: is it reality?. Therapeutic advances in psychopharmacology, 1(6), 169-74. https://doi.org/10.1177/2045125311423781
Siddiqui, Riyaz, et al. "SSRI-induced coagulopathy: is it reality?." Therapeutic advances in psychopharmacology vol. 1,6 (2011): 169-74. doi: https://doi.org/10.1177/2045125311423781
Siddiqui R, Gawande S, Shende T, Tadke R, Bhave S, Kirpekar V. SSRI-induced coagulopathy: is it reality?. Ther Adv Psychopharmacol. 2011 Dec;1(6):169-74. doi: 10.1177/2045125311423781. PMID: 23983943; PMCID: PMC3736913.
Copy Download .nbib Format: NLM
Share it on

Ther Adv Psychopharmacol. 2011 Dec;1(6):169-74. doi: 10.1177/2045125311423781.

SSRI-induced coagulopathy: is it reality?.

Therapeutic advances in psychopharmacology

Riyaz Siddiqui, Sushil Gawande, Tanaji Shende, Rahul Tadke, Sudhir Bhave, Vivek Kirpekar

PMID: 23983943 PMCID: PMC3736913 DOI: 10.1177/2045125311423781

Abstract

OBJECTIVES: To study the effect of escitalopram and fluoxetine on coagulation profile in patients with major depression.

METHOD: This was a prospective, open-label, single-centre study in 40 patients diagnosed with major depressive disorder. The patients were diagnosed using Diagnostic and Statistical Manual of Mental Disorders, fourth edition criteria. Twenty patients receiving escitalopram 10 mg per day and 20 patients receiving fluoxetine 20 mg per day participated in the study and were followed up for 3 months. Coagulation parameters - bleeding time, clotting time, platelet count, prothrombin time and partial thromboplastin kaolin time - were evaluated at baseline and after 3 months.

RESULTS: At the end of 3 months, a significant increase in bleeding time was seen in patients receiving fluoxetine, but within the normal range. No rise was seen in the group given escitalopram.

CONCLUSION: In patients with depression, fluoxetine increases bleeding time whereas escitalopram has no effect on coagulation profile. However, both the drugs can be used safely for long-term treatment.

Keywords: SSRI; coagulopathy; escitalopram; fluoxetine

References

  1. J Clin Psychiatry. 2010 Dec;71(12):1565-75 - PubMed
  2. Arch Intern Med. 2003 Jan 13;163(1):59-64 - PubMed
  3. Psychosomatics. 2009 May-Jun;50(3):297-8 - PubMed
  4. Eur J Clin Pharmacol. 2001 May;57(2):167-76 - PubMed
  5. Br J Clin Pharmacol. 2011 Jan;71(1):116-20 - PubMed
  6. J Clin Psychiatry. 2004 Dec;65(12):1642-53 - PubMed
  7. J Child Adolesc Psychopharmacol. 2000 Spring;10(1):35-8 - PubMed
  8. Arch Intern Med. 2008 Jan 28;168(2):180-5 - PubMed
  9. Expert Opin Drug Saf. 2005 Mar;4(2):337-44 - PubMed
  10. Aliment Pharmacol Ther. 2006 Apr 1;23(7):937-44 - PubMed
  11. Nervenarzt. 2010 May;81(5):549-55 - PubMed
  12. CNS Drugs. 2006;20(2):143-51 - PubMed
  13. Acta Haematol. 2006;115(3-4):157-61 - PubMed
  14. Turk Psikiyatri Derg. 2002 Winter;13(4):320-4 - PubMed
  15. Indian J Pharmacol. 2009 Feb;41(1):51-3 - PubMed

Publication Types